181 filings
Page 4 of 10
8-K
qf29h
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
8-K
4yi0 mv7cpdakeh5z
18 Mar 21
Entry into a Material Definitive Agreement
5:13pm
8-K
hvk0 2bivdz9j
2 Mar 21
Entry into a Material Definitive Agreement
5:02pm
8-K
qorjvpwg7792gpzjb
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
3mi53ufs a8udzf32
14 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
khi3bhxt1km ka9d
11 Jan 21
Regulation FD Disclosure
6:30am
8-K
mr5op2u
7 Dec 20
Other Events
4:30pm
8-K
18v4yix55mic8c3n8zh9
12 Nov 20
Agile Therapeutics Reports Third Quarter 2020 Financial Results
4:10pm
8-K
vu0li8k nta48yucloa0
21 Sep 20
Regulation FD Disclosure
4:10pm
8-K
1tpmqe96 4z1
17 Aug 20
Departure of Directors or Certain Officers
4:30pm
8-K
8m3b2u
11 Aug 20
Agile Therapeutics Reports Second Quarter 2020 Financial Results
4:10pm
8-K
vrhcr9y 0q1qga3
29 Jun 20
Other Events
12:00am
8-K
qnrgtl
9 Jun 20
Departure of Directors or Certain Officers
4:30pm
8-K
k3bp5t0y
5 May 20
Agile Therapeutics Reports First Quarter 2020 Financial Results
4:11pm
8-K
lzqxlz1ox
5 May 20
Entry into a Material Definitive Agreement
8:00am
8-K
n3tr 28qnazhiwx
22 Apr 20
Agile Therapeutics Announces Changes to its Board of Directors
4:30pm
8-K
3pvfcl
26 Feb 20
Regulation FD Disclosure
4:29pm
8-K
d32cyedn2k z98
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
8-K
8x3e8w3hh fv3aq6xzr
20 Feb 20
Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
4:27pm
8-K
5e65p1t0aj
18 Feb 20
Regulation FD Disclosure
8:50am